Maria Grosheva Selected Research

Facial Nerve Injuries

5/2016	Comparison of trophic factors' expression between paralyzed and recovering muscles after facial nerve injury. A quantitative analysis in time course.
3/2016	FGF-2 is required to prevent astrogliosis in the facial nucleus after facial nerve injury and mechanical stimulation of denervated vibrissal muscles.
1/2009	Schwann cells overexpressing FGF-2 alone or combined with manual stimulation do not promote functional recovery after facial nerve injury.
1/2005	Factors limiting motor recovery after facial nerve transection in the rat: combined structural and functional analyses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Grosheva Research Topics

Disease

4	Sialorrhea 05/2022 - 01/2019
4	Facial Nerve Injuries 05/2016 - 01/2005
3	Neoplasms (Cancer) 05/2022 - 05/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2019 - 01/2019
2	Peripheral Nerve Injuries 01/2018 - 05/2016
2	Salivary Gland Neoplasms (Salivary Gland Cancer) 04/2012 - 05/2011
1	Apnea 04/2022
1	Hyperkinesis 07/2021
1	Synkinesis 07/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021
1	Pain (Aches) 01/2021
1	Postoperative Pain 01/2021
1	Spinal Cord Injuries (Spinal Cord Injury) 03/2019
1	Dyspnea (Shortness of Breath) 01/2019
1	Paralysis (Palsy) 01/2019
1	Parotid Neoplasms 01/2018
1	Dystonia (Limb Dystonia) 08/2017
1	Gliosis 03/2016
1	Otitis Media 06/2015
1	Salivary Gland Calculi (Sialolithiasis) 04/2012
1	Acinar Cell Carcinoma 04/2012
1	Fibrosis (Cirrhosis) 01/2009

Drug/Important Bio-Agent (IBA)

3	Type A Botulinum Toxins (Botox)FDA Link 05/2022 - 07/2021
3	Nerve Growth Factors (Neurotrophins)IBA 01/2018 - 01/2005
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 05/2016 - 01/2009
2	Botulinum Toxins (Botulinum Toxin)IBA 07/2021 - 08/2017
2	SolutionsIBA 06/2019 - 01/2019
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 06/2019 - 01/2019
2	CytokinesIBA 01/2018 - 05/2016
1	Pharmaceutical PreparationsIBA 05/2022
1	incobotulinumtoxinA FDA Link 05/2022
1	Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA 01/2021
1	Local AnestheticsIBA 01/2021
1	Ropivacaine (Naropin)FDA LinkGeneric 01/2021
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	Anesthetics (Anesthetic Agents)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2019
1	Insulin (Novolin)FDA Link 05/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2016
1	Nerve Growth Factor (NGF)IBA 05/2016
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2016
1	Nasal Decongestants (Decongestants)IBA 06/2015
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 04/2012
1	Indicators and Reagents (Reagents)IBA 05/2011
1	SurvivinIBA 05/2011
1	Neutralizing AntibodiesIBA 01/2005

Therapy/Procedure

7	Therapeutics 07/2021 - 05/2011
2	Neck Dissection (Radical Neck Dissection) 05/2022 - 01/2021
1	Decompression 04/2022
1	Injections 07/2021
1	Pain Management 01/2021
1	Catheters 01/2021
1	Molecular Targeted Therapy 01/2018
1	Drug Therapy (Chemotherapy) 01/2018
1	Conservative Treatment 04/2012
1	Denervation 01/2009